Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1573.40 37.05 (2.41%) | NSE 1570.00 39.20 (2.56%) | Trade | Add

BSE Live

Mar 25, 15:40

1573.40 37.05 (2.41%)

Volume

AVERAGE VOLUME

5-Day

57,018

10-Day

149,346

30-Day

88,203

24,339

Prev. Close

1536.35
Open Price

1532.85

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Mar 25, 15:52

1570.00 39.20 (2.56%)

Volume

AVERAGE VOLUME

5-Day

202,964

10-Day

275,242

30-Day

210,829

657,174

Prev. Close

1530.80
Open Price

1530.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Ipca Laboratories (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	4,307.29	3,579.65	3,168.04	3,094.70	2,803.79
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	25.81	56.01	39.40
Revenue From Operations [Net]	4,307.29	3,579.65	3,142.23	3,038.69	2,764.39
Total Operating Revenues	4,367.43	3,633.15	3,193.40	3,102.21	2,803.66
Other Income	64.69	54.59	39.54	20.65	27.67
Total Revenue	4,432.12	3,687.74	3,232.94	3,122.86	2,831.33
EXPENSES
Cost Of Materials Consumed	1,431.10	1,098.02	923.20	947.31	886.01
Purchase Of Stock-In Trade	204.65	167.87	168.30	161.84	138.33
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-155.05	-106.14	20.98	-1.73	22.26
Employee Benefit Expenses	870.79	752.24	712.78	674.93	603.35
Finance Costs	15.79	18.49	24.02	23.34	28.60
Depreciation And Amortisation Expenses	178.69	171.88	174.36	171.00	161.23
Other Expenses	1,101.18	1,027.99	926.50	887.97	880.10
Total Expenses	3,647.15	3,130.35	2,950.14	2,864.66	2,719.88
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	784.97	557.39	282.80	258.20	111.45
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	784.97	557.39	282.80	258.20	111.45
Tax Expenses-Continued Operations
Current Tax	137.98	119.90	60.01	56.95	21.64
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-5.47	-12.40	-9.98	13.00	-2.71
Tax For Earlier Years	0.00	-5.02	-0.34	-0.04	0.00
Total Tax Expenses	132.51	102.48	49.69	69.91	18.93
Profit/Loss After Tax And Before ExtraOrdinary Items	652.46	454.91	233.11	188.29	92.52
Profit/Loss From Continuing Operations	652.46	454.91	233.11	188.29	92.52
Profit/Loss For The Period	652.46	454.91	233.11	188.29	92.52
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	51.64	36.01	18.47	14.92	7.33
Diluted EPS (Rs.)	51.60	36.01	18.47	14.92	7.33
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	257.80
Indigenous Raw Materials	0.00	0.00	0.00	0.00	472.84
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	4.44
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	28.66
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	101.08	12.64	12.62	0.00	12.62
Tax On Dividend	20.77	2.60	2.56	0.00	2.57
Equity Dividend Rate (%)	250.00	150.00	50.00	50.00	0.00